epilepsia in boli metabolice [Compatibility Mode]
epilepsia in boli metabolice [Compatibility Mode]
epilepsia in boli metabolice [Compatibility Mode]
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Afectarea sistemelor de neurotransmitatori<br />
Hiperglic<strong>in</strong>emie noncetotica<br />
Afectiune meta<strong>boli</strong>ca meta<strong>boli</strong>ca (blocarea conversiei glic<strong>in</strong>ei glic<strong>in</strong>ei <strong>in</strong> molecule mai mici);<br />
Debut precoce <strong>in</strong> perioada neonatala cu letargie, hipotonie, sughit,<br />
oftalmoplegie, tulburari ale functiilor vegetative ale trunchiului cerebral;<br />
evolutia se face spre tetraplegie, retard mental sever<br />
Epilepsia severa severa apare <strong>in</strong> cursul urmatoarelor luni (<strong>in</strong>itial mioclonii si<br />
crize generalizate, apoi spasme <strong>in</strong>fantile si convulsii partiale motorii<br />
In primele zile EEG arata explozii de varfuri (burst suppression pattern)<br />
care se transforma <strong>in</strong> activitate lenta cu voltaj mare, si eventual <strong>in</strong><br />
hipsaritmie p <strong>in</strong> j jurul a 3 luni ( (daca copilul p supravietuieste) p ) ( (Applegarth pp g<br />
and Toone 2004).<br />
Diagnostic:<br />
Cresterea concentratiei de glic<strong>in</strong>a <strong>in</strong> fluide; raport crescut al glic<strong>in</strong>ei <strong>in</strong><br />
LCR/plasma (> 0.08);<br />
Scaderea activitatii de degradare hepatica a glic<strong>in</strong>ei; analiza genetica<br />
IRM normal sau agenezie/hipoplazie a corpului calos<br />
Glic<strong>in</strong>a este neurotransmitatorul <strong>in</strong>hibitor major <strong>in</strong> maduva si trunchiul<br />
cerebral; se presupune ca simptomatologia <strong>in</strong>itiala este dara de <strong>in</strong>hibitia<br />
excesiva i l la nivelul i l l acestor t structuri. t t i<br />
Glic<strong>in</strong>a poate actiona si pe post de coactivator al receptorului NMDA<br />
(Thomson 1990).<br />
In hiperglic<strong>in</strong>emia noncetotica se presupune ca glic<strong>in</strong>a suprasatureaza situl,<br />
ducand la la stiumulare stiumulare excitatorie excitatorie excesiva excesiva si toxicitate posts<strong>in</strong>aptica<br />
posts<strong>in</strong>aptica.<br />
Adm<strong>in</strong>istrarea de benzoat de sodiu (scaderea nivelului glic<strong>in</strong>ei) ar<br />
prelungi supravietuirea. Adm<strong>in</strong>istrarea de antagonisti NMDA a avut<br />
unele efecte asupra EEG si a convulsiilor (Hamosh et al. 1998).<br />
Copii care supravietuiesc prez<strong>in</strong>ta prez<strong>in</strong>ta epilepsie epilepsie severa. severa Teoretic acidul<br />
valproic trebuie evitat, acesta <strong>in</strong>hiband suplimentar sistemul de<br />
degradare hepatica a glic<strong>in</strong>ei (Jaeken et al. 1977, MacDermot et al.<br />
1980).<br />
THE GLYCINE CLEAVAGE SYSTEM.<br />
P-prote<strong>in</strong> catalyzes the decarboxylation of<br />
the glyc<strong>in</strong>e molecule concomitantly with the<br />
transfer of the residual am<strong>in</strong>omethyl group<br />
to a sulfur atom on the lipoyl group of the<br />
oxidized H-prote<strong>in</strong> (Hox), generat<strong>in</strong>g the<br />
am<strong>in</strong>omethylated H-prote<strong>in</strong> (Ham).<br />
T-prote<strong>in</strong> catalyzes the transfer of a<br />
methylene group from Ham to<br />
tetrahydrofolate (THF), result<strong>in</strong>g <strong>in</strong> the<br />
release of NH3 and the generation of<br />
reduced H-prote<strong>in</strong> (Hred).<br />
The dihydrolipoyl group of Hred is oxidized<br />
by L-prote<strong>in</strong> L prote<strong>in</strong> and the lipoyl group of Hox is<br />
regenerated, thereby complet<strong>in</strong>g the<br />
catalytic cycle. (Douce et al, 2001).